Protalix BioTherapeutics (PLX) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 984.98% |
| Dec 31, 2025 | 154.39% |
| Sep 30, 2025 | 28.68% |
| Jun 30, 2025 | -3.46% |
| Mar 31, 2025 | -226.74% |
| Dec 31, 2024 | -2.78% |
| Sep 30, 2024 | 213.71% |
| Jun 30, 2024 | -186.20% |
| Mar 31, 2024 | 16.50% |
| Dec 31, 2023 | 152.19% |
| Sep 30, 2023 | -238.51% |
| Jun 30, 2023 | 265.88% |
| Mar 31, 2023 | -14.82% |
| Dec 31, 2022 | 71.63% |
| Sep 30, 2022 | -25.12% |
| Jun 30, 2022 | -26.20% |
| Mar 31, 2022 | -14.59% |
| Dec 31, 2021 | -170.59% |
| Sep 30, 2021 | -128.85% |
| Jun 30, 2021 | 166.26% |
| Mar 31, 2021 | -30.25% |
| Dec 31, 2020 | -109.49% |
| Sep 30, 2020 | 54.00% |
| Jun 30, 2020 | -10.09% |
| Mar 31, 2020 | -93.03% |
| Dec 31, 2019 | -14.33% |
| Sep 30, 2019 | 37.62% |
| Jun 30, 2019 | 28.94% |
| Mar 31, 2019 | -81.72% |
| Dec 31, 2018 | -129.36% |
| Sep 30, 2018 | 271.26% |
| Jun 30, 2018 | 15.39% |
| Mar 31, 2018 | -153.16% |
| Dec 31, 2017 | 266.18% |
| Sep 30, 2017 | -25.40% |
| Jun 30, 2017 | 0.60% |
| Mar 31, 2017 | -16.32% |
| Dec 31, 2016 | -114.13% |
| Sep 30, 2016 | 71.52% |
| Jun 30, 2016 | -30.01% |
| Mar 31, 2016 | -73.46% |
| Dec 31, 2015 | 46.06% |
| Sep 30, 2015 | -127.51% |
| Jun 30, 2015 | 29.40% |
| Mar 31, 2014 | -535.74% |
| Dec 31, 2013 | 123.30% |
| Sep 30, 2013 | -1.32% |
| Jun 30, 2013 | 15.41% |
| Mar 31, 2013 | -626.41% |
| Dec 31, 2012 | 122.68% |
| Sep 30, 2012 | -161.18% |
| Jun 30, 2012 | 308.95% |
| Mar 31, 2012 | 5.01% |
| Dec 31, 2011 | 18.84% |
| Sep 30, 2011 | -68.92% |
| Jun 30, 2011 | -20.94% |
| Mar 31, 2011 | 50.34% |
| Dec 31, 2010 | 17.04% |